Australia markets open in 9 hours 15 minutes

Surgalign Holdings, Inc. (SRGA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1200-0.0200 (-0.93%)
At close: 03:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.1400
Open2.1000
Bid2.0300 x 1100
Ask2.3700 x 1000
Day's range2.0500 - 2.1700
52-week range1.3400 - 19.5000
Volume16,970
Avg. volume66,616
Market cap27.044M
Beta (5Y monthly)1.74
PE ratio (TTM)N/A
EPS (TTM)-14.8540
Earnings date13 Mar 2023 - 17 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.25
  • GlobeNewswire

    Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System

    DEERFIELD, Ill., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced a key milestone for its recently introduced posterior fixation platform – the Cortera™ Spinal Fixation System. Surgalign received FDA 510(k) in August 2022 and Cortera and was introduced in a limited market release shortly thereafter. In a little over three months, the

  • GlobeNewswire

    Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance System in Virginia

    Richmond, VA medical facility is fourth to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgeryDEERFIELD, Ill., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced additional commercialization of its HOLO Portal surgical guidance system. The Company is

  • GlobeNewswire

    Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

    DEERFIELD, Ill., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that the closing of its previously announced registered direct offering priced at the market under Nasdaq rules of 6,000,000 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and Series A warrants to purchase up to 6,000,000 shares of common